Skip to main content
. 2017 May 18;45(Web Server issue):W207–W214. doi: 10.1093/nar/gkx398

Figure 2.

Figure 2.

Recapitulation of a published colorectal cancer (CRC) study. As a proof-of-concept case study, GeMSTONE recapitulated every step in the original Colorectal-cancer prioritization workflow1, rescuing 27 out of 28 candidate variants from the ∼30,000 variants in the raw whole exome sequencing dataset and hitting all hereditary CRC and CRC GWAS variants.